These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

127 related items for PubMed ID: 3904651

  • 1. Antihypertensive effects of a novel phenylpiperazine derivative, SGB-1534, on several hypertensive models of rats.
    Nabata H, Aono J, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):104-18. PubMed ID: 3904651
    [Abstract] [Full Text] [Related]

  • 2. Mechanism of the hypotensive effect of a novel phenylpiperazine derivative, SGB-1534: antagonism at alpha 1-adrenergic and 5-HT2 receptors.
    Aono J, Nabata H, Ishizuka N, Sakai K.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):126-39. PubMed ID: 2865933
    [Abstract] [Full Text] [Related]

  • 3. Alpha-adrenoceptor antagonistic effects and antihypertensive activity of SGB-1534 in conscious normotensive and deoxycorticosterone acetate (DOCA)-salt hypertensive dogs: comparison with prazosin.
    Haruta K, Baba A, Akima M, Koga T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1989 Sep; 299():169-84. PubMed ID: 2570554
    [Abstract] [Full Text] [Related]

  • 4. Long-lasting hypotensive and antihypertensive effects of a new 1,5-benzothiazepine calcium antagonist in hypertensive rats and renal hypertensive dogs.
    Narita H, Murata S, Yabana H, Kikkawa K, Sugawara Y, Akimoto Y, Nagao T.
    Arzneimittelforschung; 1988 Apr; 38(4):515-20. PubMed ID: 3041970
    [Abstract] [Full Text] [Related]

  • 5. Antihypertensive action of a novel orally active angiotensin converting enzyme inhibitor altiopril calcium (MC-838) in several hypertensive models of rats: comparison with captopril.
    Aono J, Koga T, Yamazaki T, Shiraki Y, Sakai K.
    Arch Int Pharmacodyn Ther; 1988 Apr; 292():203-22. PubMed ID: 3293542
    [Abstract] [Full Text] [Related]

  • 6. Pharmacological studies on a new dihydrothienopyridine calcium antagonist. 3rd communication: antihypertensive effects of S-(+)-methyl-4,7-dihydro-3-isobutyl-6-methyl-4-(3-nitrophenyl)thieno[2, 3-b] pyridine-5-carboxylate in hypertensive rats and dogs.
    Ueda M, Matsumura S, Masui M, Matsuura E, Kawakami M, Fujitomo H, Umeda T, Kagawa H, Hirohata S, Shima K.
    Arzneimittelforschung; 1993 Dec; 43(12):1282-90. PubMed ID: 8141815
    [Abstract] [Full Text] [Related]

  • 7. Protective effects of the angiotensin II type 1 (AT1) receptor blockade in low-renin deoxycorticosterone acetate (DOCA)-treated spontaneously hypertensive rats.
    Chamorro V, Wangensteen R, Sainz J, Duarte J, O'Valle F, Osuna A, Vargas F.
    Clin Sci (Lond); 2004 Mar; 106(3):251-9. PubMed ID: 14521506
    [Abstract] [Full Text] [Related]

  • 8. Effects of SGB-1534, a new synthesized phenylpiperazine derivative, on blood pressure and heart rate in stroke-prone spontaneously hypertensive rats.
    Matsumoto M, Yoshioka M, Togashi H, Minami M, Nagao A, Saito H.
    Hokkaido Igaku Zasshi; 1988 Jan; 63(1):36-43. PubMed ID: 2896150
    [Abstract] [Full Text] [Related]

  • 9. Nonpeptide angiotensin II receptor antagonists. IX. Antihypertensive activity in rats of DuP 753, an orally active antihypertensive agent.
    Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PB.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):726-32. PubMed ID: 2179532
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological profile of valsartan, a non-peptide angiotensin II type 1 receptor antagonist. 1st communication: antihypertensive effects of valsartan in hypertensive models.
    Yamamoto S, Hayashi N, Kometani M, Nakao K, Inukai T.
    Arzneimittelforschung; 1997 May; 47(5):604-12. PubMed ID: 9205773
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive properties of a new long-acting angiotensin converting enzyme inhibitor in renin-dependent and independent hypertensive models.
    Nagata S, Takeyama K, Fukuya F, Nagai R, Hosoki K, Nishimura K, Deguchi T, Karasawa T.
    Arzneimittelforschung; 1995 Aug; 45(8):853-8. PubMed ID: 7575746
    [Abstract] [Full Text] [Related]

  • 12. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R, Tagawa T, Ishida T, Naruse T.
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [Abstract] [Full Text] [Related]

  • 13. Cardiovascular effects of a novel antihypertensive agent, SGB-1534, in miniature pigs.
    Sakai K, Kuromaru O, Akima M, Yoshizawa M.
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):119-25. PubMed ID: 4062428
    [Abstract] [Full Text] [Related]

  • 14. Antihypertensive effects of nisoldipine and reference drugs in certain types of hypertensive rats.
    Tasaka K, Kamei C, Tagami H, Hokonohara T, Sugimoto Y.
    Arzneimittelforschung; 1987 Mar; 37(3):316-21. PubMed ID: 3297074
    [Abstract] [Full Text] [Related]

  • 15. Hypotensive and hemodynamic effects of the new non-sulfhydryl angiotensin converting enzyme inhibitor N-[8-amino-1(S)-carboxyoctyl]-L-alanyl-L-proline.
    Shirota M, Iijima M, Ushijima T, Kajiwara Y, Kitabatake K.
    Arzneimittelforschung; 1990 Dec; 40(12):1303-9. PubMed ID: 2095126
    [Abstract] [Full Text] [Related]

  • 16. [The hypotensive effects and mechanism of SGB-483, a newly-synthesized hypotensive agent].
    Chin W, Nakagawa Y, Mitomi A, Imai S.
    Nihon Yakurigaku Zasshi; 1982 May; 79(5):441-9. PubMed ID: 6127291
    [Abstract] [Full Text] [Related]

  • 17. Antihypertensive action of the novel angiotensin converting enzyme inhibitor benazepril hydrochloride in hypertensive rat models.
    Tanaka M, Yamamoto S, Nakao K, Inukai T, Ogawa N, Katsumura H, Ohara N, Shukunobe K, Ono H.
    Arzneimittelforschung; 1991 Jun; 41(6):608-12. PubMed ID: 1930348
    [Abstract] [Full Text] [Related]

  • 18. Antihypertensive effect of the new calcium antagonist (+-)-3-(benzylmethylamino)-2,2-dimethylpropyl-methyl-4-(2-fluoro-5- nitrophenyl)-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylate hydrochloride in rats.
    Okamiya Y, Kishimoto T, Sunakawa K, Aoki K, Tanabe H, Takeshita T, Naruchi T.
    Arzneimittelforschung; 1992 Jan; 42(1):9-16. PubMed ID: 1586389
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.